News

News


Cresset and Syrris Begin Strategic Partnership

23 March 2010

Syrris has partnered with Cresset to launch MedStere to increase lead optimisation efficiency. Medstere is innovative bioisostere replacement software designed specifically for medicinal chemists. It shortens lead optimization cycles by suggesting thousands of obvious and non-obvious alternatives to a known lead. By intelligently ranking compounds from the view point of proteins it offers structurally diverse [...]

Read Article


Cresset Introduces FieldStere V2.0

10 March 2010

Cresset today announced the release of a new version of its FieldStere bioisostere generator. FieldStere delivers shorter lead optimization cycles to computational and medicinal chemists by enabling them to choose the best syntheses, to fine-tune portions of lead molecules and to scaffold hop to expand into new areas of chemical space. FieldStere V2.0 is the [...]

Read Article


Cresset Establishes New Versaphor Division

02 March 2010

Versaphor offers molecular Field enabled tools to medicinal chemistry, patent, safety and in-licensing teams Welwyn Garden City – Cresset today announced that it has launched Versaphor, a new desktop applications division aimed at supplying high quality tools based on its molecular Fields technology to a range of markets, including: medicinal chemists, patent teams (internal and [...]

Read Article


FieldScreen 2.5.0 released

08 October 2009

New release of FieldScreen, efficient ligand based virtual screening. This release includes major improvements for system administrators and users. New features in the latest release of FieldScreen The latest version of FieldScreen brings significant improvements in system management and major enhancements in result visualisation with FieldView 1.1.0. FieldScreen 2.5.0, new management features Faster – new [...]

Read Article


New Services Launched

29 September 2009

New Cost Efficient Lead Finding and Optimization Services Launched Cresset specializes in the use of molecular Fields to help identify novel active chemistry across any target family. We have an impressive track record of discovering and optimizing novel active leads for customers built over 8 years. Cresset has a success rate of over 80% across [...]

Read Article